The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Confirmation of Exchange Rate

25 Jul 2023 07:00

RNS Number : 0308H
WANdisco Plc
25 July 2023
 

25 July 2023

 

WANdisco plc

 

Confirmation of Exchange Rate

 

WANdisco plc (the "Company") (LSE: WAND), the data activation platform, confirms that further to the announcement of the successful completion of the $30 million equity fundraise (the "Fundraise") on 7 July 2023 the Sterling and USD exchange rate used was 1.2624.

 

Following the previously announced bookbuild process 47,528,517 New Ordinary Shares will be issued at the Offer Price of 50 pence per share, equivalent to £23.76 million. This bookbuild process followed the consultative process with shareholders in the Exploring Funding Options announcement on 15 May 2023, prior to which the Company had made several notifications regarding the Irregularities and its financial position, including: the initial Trading Revision announcement on 9 March 2023; the Independent Investigation Appointment announcement on 10 March 2023; the Board Change and Investigation Update announcement on 3 April; the FCA Investigation announcement on 20 April; the Independent Investigation Update announcement on 28 April. On 28 June, the Company announced an Update on Timing of Results and Equity Issue prior to the Launch of Fundraise announcement on 3 July 2023.

Admission and lifting of the suspension of Ordinary Shares to trading on AIM

Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will be effective and settlement of the New Ordinary Shares will commence at 8.00 a.m., today on 25 July 2023.

The Company published its FY22 Annual Report & Accounts on 12 July 2023, following which the Company and its nominated adviser have requested that the suspension of the Ordinary Shares to trading on AIM be lifted at 7.30 a.m., today on 25 July 2023.

Capitalised terms used but not defined in this announcement shall have the meaning given to them in the Company's Launch Announcement of 3 July 2023, unless context provides otherwise.

 

For further information, please contact:

 

FTI Consulting

Rob Mindell / Kwaku Aning / Matt Dixon

+44 (0)20 3727 1137

Stifel (Nomad and Joint Broker)

Fred Walsh / Richard Short / Tom Marsh

+44 (0)20 7710 7600

Liberum (Joint Broker)

Max Jones / Ben Cryer / Miquela Bezuidenhoudt

+44 (0)20 3100 2000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSAUROAUBUUR
Date   Source Headline
27th Feb 20197:00 amRNSHolding(s) in Company
20th Feb 20192:42 pmRNSHolding(s) in Company
15th Feb 20193:11 pmRNSHolding(s) in Company
14th Feb 20197:00 amRNSAdvanced Technology Partner status with AWS
14th Feb 20197:00 amRNSSubscription for shares raising $17.5m
1st Feb 20197:00 amRNSTotal Voting Rights
10th Jan 20199:02 amRNSTotal Voting Rights
9th Jan 20194:35 pmRNSPrice Monitoring Extension
8th Jan 20197:00 amRNSSQL product launch with IBM
3rd Jan 20197:00 amRNSInaugural Multi-Cloud Contract Win
27th Dec 20187:00 amRNSHealthcare Contract Win
13th Dec 20187:00 amRNSSignificant health insurance contract win
10th Dec 20187:00 amRNSDirector Dealings and Issue of Equity
3rd Dec 20187:00 amRNSBlock admission notification
3rd Dec 20187:00 amRNSTotal Voting Rights
19th Nov 20187:00 amRNSHire of SVP of marketing
19th Nov 20187:00 amRNSBoard change
7th Nov 201810:29 amRNSTotal Voting Rights
5th Nov 20187:00 amRNSContract win
31st Oct 20187:00 amRNSDirector Dealings
24th Oct 201811:11 amRNSDirector Dealings and Issue of Equity
17th Oct 20187:00 amRNSWANdisco launches LiveData for Multicloud
16th Oct 20189:32 amRNSDirector Dealings and Issue of Equity
12th Oct 20187:00 amRNSDirector/PDMR Shareholding
3rd Oct 20185:34 pmRNSDirector Dealings and Issue of Equity
2nd Oct 20188:27 amRNSTotal Voting Rights
25th Sep 20187:01 amRNSAutomotive contract win
25th Sep 20187:00 amRNSHalf-year Report
3rd Sep 20187:30 amRNSTotal Voting Rights
3rd Sep 20187:00 amRNSWANdisco plc Trading Update
1st Aug 20187:00 amRNSWANdisco's Total Voting Rights
25th Jul 20187:00 amRNSNew blockchain patent filing and VP of Engineering
3rd Jul 20189:00 amRNSWANdisco Total Voting Rights
29th May 20184:55 pmRNSBlock Listing Six Monthly Return
23rd May 201811:27 amRNSResult of AGM
22nd May 201812:05 pmRNSHolding(s) in Company
2nd May 20186:19 pmRNSTotal Voting Rights
25th Apr 20182:54 pmRNSHolding(s) in Company
16th Apr 20184:02 pmRNSHolding(s) in Company
4th Apr 20183:11 pmRNSHolding(s) in Company
3rd Apr 20184:56 pmRNSTotal Voting Rights
27th Mar 20181:44 pmRNSHolding(s) in Company
14th Mar 20187:00 amRNSDirector/PDMR Dealing
12th Mar 20187:00 amRNSWANdisco announces Co-Sell status with Microsoft
7th Mar 20187:00 amRNSAppointment of Joint Corporate Broker
7th Mar 20187:00 amRNSOEM SALES PARTNERSHIP WITH ALIBABA CLOUD
7th Mar 20187:00 amRNSPreliminary Results
2nd Mar 20187:18 amRNSTotal Voting Rights
26th Feb 201810:02 amRNSNotice of Results
1st Feb 20185:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.